Lactylation: a metabolic–epigenetic driver in atherosclerosis pathogenesis and therapeutic targeting - Top-Institutions - MDSpire

Lactylation: a metabolic–epigenetic driver in atherosclerosis pathogenesis and therapeutic targeting

  • By

  • Wenbo Lv

  • Linxi Xie

  • Jintao Tao

  • Qingqi Xu

  • Wenfeng Hu

  • Hao Xie

  • Pin Lu

  • Ying Xu

  • Liang Huang

  • June 26, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Zhongshan Hospital, Fudan University
    Zhongshan Hospital, Fudan University

    Shanghai, China

    Key Differentiators

    • Cardiology
    • Vascular Surgery

  • #2

    The First Affiliated Hospital of Nanjing Medical University
    The First Affiliated Hospital of Nanjing Medical University

    Nanjing, China

    Key Differentiators

    • Cardiology
    • Cardiovascular Surgery

Original Source(s)

Lactylation: a metabolic–epigenetic driver in atherosclerosis pathogenesis and therapeutic targeting

  • by Wenbo Lv, Linxi Xie, Jintao Tao, Qingqi Xu, Wenfeng Hu, Hao Xie, Pin Lu, Ying Xu, Liang Huang

  • June 26, 2026

Related Content

Editorial: HDL and cardiovascular disease: mechanisms, clinical relevance, and therapeutic impacts

Large Language Model Summarization of Physician-to-Physician Calls for Interhospital Transfer of Patients With ST-Elevation Myocardial Infarction: Observational Study

QTc interval prolongation in pediatric eating disorder population